-
1
-
-
0038011833
-
Evolving concepts of rheumatoid arthritis
-
Firestein GS. Evolving concepts of rheumatoid arthritis.Nature 2003;423: 356-361.
-
(2003)
Nature
, vol.423
, pp. 356-361
-
-
Firestein, G.S.1
-
3
-
-
34247589636
-
Cells of the synovium in rheumatoid arthritis
-
Schett G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther 2007;9: 203.
-
(2007)
Osteoclasts. Arthritis Res Ther
, vol.9
, pp. 203
-
-
Schett, G.1
-
4
-
-
80053474869
-
Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis
-
Zhao S Guo, YY Ding N, Yang LL Zhang N, Changes in serum levels of soluble osteoclast-associated receptor in human rheumatoid arthritis. Chin Med J.2011; 124: 3058-3060.
-
(2011)
Chin Med J
, vol.124
, pp. 3058-3060
-
-
Zhao, S.G.1
Ding, Y.Y.N.2
Yang, L.L.3
Zhang, N.4
-
5
-
-
0028865923
-
Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues
-
Yaziji H, Janckila AJ, Lear SC, Martin AW, Yam LT. Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am J Clin Pathol 1995; 104: 397-402.
-
(1995)
Am J Clin Pathol
, vol.104
, pp. 397-402
-
-
Yaziji, H.1
Janckila, A.J.2
Lear, S.C.3
Martin, A.W.4
Yam, L.T.5
-
6
-
-
47849116207
-
Significance of serum TRACP in rheumatoid arthritis
-
Janckila AJ, Neustadt DH, Yam LT. Significance of serum TRACP in rheumatoid arthritis. J Bone Miner Res 2008; 23: 1287-1295.
-
(2008)
J Bone Miner Res
, vol.23
, pp. 1287-1295
-
-
Janckila, A.J.1
Neustadt, D.H.2
Yam, L.T.3
-
7
-
-
0023945481
-
The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
-
(1988)
Arthritis Rheum
, vol.31
, pp. 315-324
-
-
Arnet, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
-
8
-
-
0026629688
-
The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
-
Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498-502.
-
(1992)
Arthritis Rheum
, vol.35
, pp. 498-502
-
-
Hochberg, M.C.1
Chang, R.W.2
Dwosh, I.3
Lindsey, S.4
Pincus, T.5
Wolfe, F.6
-
9
-
-
72649098710
-
Therapeutic criteria in rheumatoid arthritis
-
Steinbrocker O, Traeger C, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-662.
-
(1949)
JAMA
, vol.140
, pp. 659-662
-
-
Steinbrocker, O.1
Traeger, C.2
Batterman, R.C.3
-
10
-
-
0034047217
-
Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption
-
Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vaananen HK. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 2000; 15: 1337-1345.
-
(2000)
J Bone Miner Res
, vol.15
, pp. 1337-1345
-
-
Halleen, J.M.1
Alatalo, S.L.2
Suominen, H.3
Cheng, S.4
Janckila, A.J.5
Vaananen, H.K.6
-
11
-
-
0035148965
-
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity
-
Janckila AJ, Takahashi K, Sun SZ, Yam LT. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 2001; 47: 174-178.
-
(2001)
Clin Chem
, vol.47
, pp. 174-178
-
-
Janckila, A.J.1
Takahashi, K.2
Sun, S.Z.3
Yam, L.T.4
-
12
-
-
0031894140
-
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis
-
Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998; 152: 943-951.
-
(1998)
Am J Pathol
, vol.152
, pp. 943-951
-
-
Gravallese, E.M.1
Harada, Y.2
Wang, J.T.3
Gorn, A.H.4
Thornhill, T.S.5
Goldring, S.R.6
-
13
-
-
0942300651
-
Clinical performance of immunoreactive tartrateresistant acid phosphatase isoform 5b as a marker of bone resorption
-
Hannon RA, Clowes JA, Eagleton AC, Al Hadari A, Eastell R, Blumsohn A. Clinical performance of immunoreactive tartrateresistant acid phosphatase isoform 5b as a marker of bone resorption. Bone 2004; 34: 187-189.
-
(2004)
Bone
, vol.34
, pp. 187-189
-
-
Hannon, R.A.1
Clowes, J.A.2
Eagleton, A.C.3
Al, H.A.4
Eastell, R.5
Blumsohn, A.6
-
14
-
-
0036241628
-
Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis
-
Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T, Yam LT. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clin Chim Acta 2002; 320: 49-58.
-
(2002)
Clin Chim Acta
, vol.320
, pp. 49-58
-
-
Janckila, A.J.1
Neustadt, D.H.2
Nakasato, Y.R.3
Halleen, J.M.4
Hentunen, T.5
Yam, L.T.6
-
15
-
-
0038166881
-
Tartrate-resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma
-
Terpos E, de la Fuente J, Syzdlo R, Hatjiharissi E, Viniou N, Meletis J, et al. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Int J Cancer 2003; 106: 455-457.
-
(2003)
Int J Cancer
, vol.106
, pp. 455-457
-
-
Terpos, E.1
de la Fuente, J.2
Syzdlo, R.3
Hatjiharissi, E.4
Viniou, N.5
Meletis, J.6
-
16
-
-
0043125544
-
Tartrate-resistant acid phosphatase 5b as a serum marker of bone metabolism in cancer patients
-
Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K, et al. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metabolism in cancer patients. Anticancer Res 2003; 23: 2783-2788.
-
(2003)
Anticancer Res
, vol.23
, pp. 2783-2788
-
-
Mose, S.1
Menzel, C.2
Kurth, A.A.3
Obert, K.4
Breidert, I.5
Borowsky, K.6
-
17
-
-
2942730031
-
Biochemical markers of bone metabolism and prediction of fracture in elderly women
-
Gerdhem P, Ivaska KK, Alatalo SL, Halleen JM, Hellman J, Isaksson A, et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res 2004; 19: 386-393.
-
(2004)
J Bone Miner Res
, vol.19
, pp. 386-393
-
-
Gerdhem, P.1
Ivaska, K.K.2
Alatalo, S.L.3
Halleen, J.M.4
Hellman, J.5
Isaksson, A.6
-
18
-
-
34547636701
-
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis
-
Tsai SH, Chen CY, Ku CH, Janckila AJ, Yam LT, Yu JC, et al. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis. Mayo Clin Proc 2007; 82: 917-926.
-
(2007)
Mayo Clin Proc
, vol.82
, pp. 917-926
-
-
Tsai, S.H.1
Chen, C.Y.2
Ku, C.H.3
Janckila, A.J.4
Yam, L.T.5
Yu, J.C.6
-
19
-
-
37248999029
-
Treatment of early rheumatoid arthritis: A randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone
-
Durez P, Malghem J, Nzeusseu Toukap A, Depresseux G, Lauwerys BR, Westhorens R, et al. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis Rheum 2007; 56: 3919-3927.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 3919-3927
-
-
Durez, P.1
Malghem, J.2
Nzeusseu, T.A.3
Depresseux, G.4
Lauwerys, B.R.5
Westhorens, R.6
-
20
-
-
42449098374
-
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
-
Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, et al. Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum 2008; 58: 953-963.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 953-963
-
-
Kremer, J.M.1
Genant, H.K.2
Moreland, L.W.3
Russell, A.S.4
Emery, P.5
Abud-Mendoza, C.6
-
21
-
-
47249103596
-
CTLA-4 directly inhibits osteoclast formation
-
Axmann R, Herman S, Zaiss M, Franz S, Polzer K, Zwerina J, et al. CTLA-4 directly inhibits osteoclast formation. Ann Rheum Dis 2008; 67: 1603-1609.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1603-1609
-
-
Axmann, R.1
Herman, S.2
Zaiss, M.3
Franz, S.4
Polzer, K.5
Zwerina, J.6
-
22
-
-
24344433524
-
Osteoclast differentiation independent of the TRANCE-RANKTRAF6 axis
-
Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, et al. Osteoclast differentiation independent of the TRANCE-RANKTRAF6 axis. J Exp Med 2005; 202: 589-595.
-
(2005)
J Exp Med
, vol.202
, pp. 589-595
-
-
Kim, N.1
Kadono, Y.2
Takami, M.3
Lee, J.4
Lee, S.H.5
Okada, F.6
-
23
-
-
0035965998
-
Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of akt and erk
-
Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, et al. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of akt and erk. J Biol Chem 2001; 276: 49343-49349.
-
(2001)
J Biol Chem
, vol.276
, pp. 49343-49349
-
-
Lee, S.E.1
Chung, W.J.2
Kwak, H.B.3
Chung, C.H.4
Kwack, K.B.5
Lee, Z.H.6
-
24
-
-
10444273254
-
Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand
-
Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Arthritis Rheum 2004; 50: 3831-3843.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 3831-3843
-
-
Lee, C.K.1
Lee, E.Y.2
Chung, S.M.3
Mun, S.H.4
Yoo, B.5
Moon, H.B.6
-
25
-
-
34247592459
-
Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis
-
Suematsu A, Tajiri Y, Nakashima T, Taka J, Ochi S, Oda H, et al. Scientific basis for the efficacy of combined use of antirheumatic drugs against bone destruction in rheumatoid arthritis. Mod Rheumatol 2007; 17: 17-23.
-
(2007)
Mod Rheumatol
, vol.17
, pp. 17-23
-
-
Suematsu, A.1
Tajiri, Y.2
Nakashima, T.3
Taka, J.4
Ochi, S.5
Oda, H.6
|